Teresa Graham

CEO Roche Pharmaceuticals (Member of the CEC since 2023)

About Roche

View all leaders

Zur deutschen Version

Personal Data

Nationality
US

Year of Birth
1973

Education

1995
The George Washington University, Washington, DC, BBA

Professional experience

2005–2007
Genentech, Senior Product Manager

2007–2010
Genentech, Group Product Manager / Associate Director GIO Pipeline Strategy & Operations

2010
Genentech, Divisional Sales Manager

2011–2012
Genentech, Marketing Director, Rituxan Immunology

2012-2013
Genentech, Marketing Director, ACTEMRA

2013-2015
Genentech, Senior Director, Field Reimbursement Management

2015-2017
Roche Pharmaceuticals Basel, Lifecycle Leader. ACTEMRA

2017
Genentech, Vice President, Rheumatology / Nephrology

2018–2019
Genentech, Vice President, Avastin, Alecensa, Tarceva and Entrectinib, Lung & GI Oncology Sales

2019–2023
Roche, Basel, Head Global Product Strategy Pharmaceuticals

Since 2023
Roche, Basel, CEO Roche Pharmaceuticals

Present external mandates

–

Other activities / non-profit activities / memberships

Since 2023
EFPIA, Board Member

Since 2023
Chugai Pharmaceutical Co., Ltd, Member of the Board of Directors

Awards / Honors

–

Möchten Sie den Inhalt auf Deutsch lesen?

Zur deutschen Version

Discover more

Board of Directors
About Roche

The Board of Directors' composition and the curricula vitae of its members.

Executive Committee
About Roche

The Executive Committee's composition and the curricula vitae of its members.

Annual General Meeting
About Roche

The General Meeting is convened by the Board of Directors, together with its agenda and the proposals of the Board of Directors and the shareholders.

Board Committees
About Roche

Our Board of Directors has delegated certain matters to four committees for detailed attention.

Code of conduct
About Roche

The Roche Group Code of Conduct states the expectations Roche as an employer has towards his employees and sets forth the standards for business behaviour that apply throughout the Roche Group.

Investors
Investors

We are committed to delivering value for all our stakeholders through continuous innovation, groundbreaking solutions, trust and sustainable business practices.